Cargando…
Current Status of Management and Outcome for Patients with Ewing Sarcoma
SIMPLE SUMMARY: Ewing sarcoma is a highly aggressive malignancy affecting primarily children and adolescents. It is the second most common bone sarcoma among children, affecting between 1 and 3 persons per million inhabitants. The tumor typically carries a pathognomonic chromosomal translocation res...
Autores principales: | Hesla, Asle Charles, Papakonstantinou, Andri, Tsagkozis, Panagiotis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998375/ https://www.ncbi.nlm.nih.gov/pubmed/33801953 http://dx.doi.org/10.3390/cancers13061202 |
Ejemplares similares
-
Transcriptome profiling of Ewing sarcomas – treatment resistance pathways and IGF‐dependency
por: Chen, Yi, et al.
Publicado: (2020) -
Subsequent primary neoplasms among bone sarcoma survivors; increased risks remain after 30 years of follow-up and in the latest treatment era, a nationwide population-based study
por: Hesla, Asle Charles, et al.
Publicado: (2020) -
Ewing sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. A Scandinavian sarcoma group study with a mean follow-up of 12 years
por: Hesla, Asle Charles, et al.
Publicado: (2018) -
Evaluation of PD-L1 Expression in Undifferentiated Pleomorphic Sarcomas, Liposarcomas and Chondrosarcomas
por: Zhang, Yifan, et al.
Publicado: (2022) -
Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas
por: Brodin, Bertha A., et al.
Publicado: (2019)